Jun. 4 at 5:39 PM
$ALVO Finally, I hope the SP moves upwards from now on. I guess the market will no longer focus on the FDA mishap, but rather on future growth rates in revenue and profit. I am in for the long run, I hope the YoY growth rate of revenue returns to about 20% in 2027, after a rather slow year 2026.
If the FDA does approve AVT03, AVT05 an AVT06 this year, this could also trigger some milestone payments from the respective partners. If this is the case, we might actually exceed
$ALVO's guidance this year. Anyway I hope we'll never see a SP below
$3. Double digits in two years from now is very well possible!
